Gonzalo Alonso Ramos Rivera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gonzalo Alonso Ramos Rivera has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Martin Kudr
Department of Paediatric Neurology, Second Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic
6 shared publications - Radek Janca
Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic
6 shared publications - Alice Maulisova
Department of Clinical Psychology Motol University Hospital, Full Member of the ERN EpiCARE and Epilepsy Research Centre Prague ‐ EpiReC Consortium Prague Czech Republic
5 shared publications - Anezka Belohlavkova
Department of Pediatric Neurology, Motol Epilepsy Center, Second Faculty of Medicine Charles University and Motol University Hospital, Full Member of the ERN EpiCARE and Epilepsy Research Centre Prague ‐ EpiReC Consortium Prague Czech Republic
5 shared publications - Martin Kynčl
Center for Pediatric Neuro-Oncology, Motol and Homolka University Hospital, Prague, Czech Republic
5 shared publications - Pavel Krsek
Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
5 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (5) , 1863-1870
Real‐world use of Cenobamate in pediatric drug‐resistant epilepsy: A European multicenter retrospective study
Pediatric drug‐resistant epilepsy (DRE) remains a significant clinical challenge, with few effective pharmacological options. This European multicenter retrospective study assessed the real‐world efficacy, tolerability, and retention of off‐label cenobamate (CNB) in 108 children and adolescents with DRE (median age: 13.83 years, range 3.9–19.8). Overall, 57/108 patients (52.8%) achieved a ≥50% seizure reduction, including 20/108 (18.5%) who were seizure‐free during the documented interval between visits. The median monthly seizure frequency declined from 30 to 9. Median follow‐up was 581.5 days (IQR 340,8; range 27–1160); 5 patients had follow‐up ≤90 days and 10 had follow‐up p = 0.0076). The initiation dose was most commonly 12.5 mg (0.25 mg/kg/day, IQR 0.12), with titration to a median maintenance dose of 3.57 mg/kg/day (IQR 1.95; range 0.3–10). These findings suggest that CNB is a generally well‐tolerated and clinically effective adjunctive treatment in pediatric DRE, with the potential to reduce polypharmacy and support long‐term adherence. Controlled prospective studies are needed to confirm these results and to establish safe, evidence‐based use of CNB in children. Plain Language Summary: Many children and adolescents with drug‐resistant epilepsy do not respond to available medications. In this European multicenter study, we evaluated cenobamate, used off label, in 108 young patients with severe epilepsy. More than half had their seizures reduced by at least 50%, and nearly one in five became seizure‐free. Seizure frequency dropped markedly, and many patients could reduce other anti‐seizure medications. Side effects were common but usually mild, and most patients continued treatment long term. These results suggest cenobamate may be a useful option in pediatric drug‐resistant epilepsy, but prospective studies are needed to confirm safety and effectiveness.
- 3 July 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (5) , 1863-1870
Open AccessReal‐world use of Cenobamate in pediatric drug‐resistant epilepsy: A European multicenter retrospective study
Pediatric drug‐resistant epilepsy (DRE) remains a significant clinical challenge, with few effective pharmacological options. This European multicenter retrospective study assessed the real‐world efficacy, tolerability, and retention of off‐label cenobamate (CNB) in 108 children and adolescents with DRE (median age: 13.83 years, range 3.9–19.8). Overall, 57/108 patients (52.8%) achieved a ≥50% seizure reduction, including 20/108 (18.5%) who were seizure‐free during the documented interval between visits. The median monthly seizure frequency declined from 30 to 9. Median follow‐up was 581.5 days (IQR 340,8; range 27–1160); 5 patients had follow‐up ≤90 days and 10 had follow‐up p = 0.0076). The initiation dose was most commonly 12.5 mg (0.25 mg/kg/day, IQR 0.12), with titration to a median maintenance dose of 3.57 mg/kg/day (IQR 1.95; range 0.3–10). These findings suggest that CNB is a generally well‐tolerated and clinically effective adjunctive treatment in pediatric DRE, with the potential to reduce polypharmacy and support long‐term adherence. Controlled prospective studies are needed to confirm these results and to establish safe, evidence‐based use of CNB in children. Plain Language Summary: Many children and adolescents with drug‐resistant epilepsy do not respond to available medications. In this European multicenter study, we evaluated cenobamate, used off label, in 108 young patients with severe epilepsy. More than half had their seizures reduced by at least 50%, and nearly one in five became seizure‐free. Seizure frequency dropped markedly, and many patients could reduce other anti‐seizure medications. Side effects were common but usually mild, and most patients continued treatment long term. These results suggest cenobamate may be a useful option in pediatric drug‐resistant epilepsy, but prospective studies are needed to confirm safety and effectiveness.
- 27 May 2026
- Published by Wiley in Epileptic Disorders
- Vol. 28 (5) , 1470-1481
Electroclinical characteristics, genetic findings, and complex epilepsy surgery outcomes in children with low‐grade epilepsy‐associated tumors: A comprehensive view
Objective: To evaluate outcomes in relation to epilepsy characteristics and genetic findings in pediatric patients with isolated low‐grade epilepsy‐associated tumors (LEAT) and LEAT plus focal cortical dysplasia type IIIb (FCD IIIb) who underwent epilepsy surgery. Methods: Patients younger than 19 years at the time of surgery, with isolated LEAT or LEAT plus FCD IIIb, and a minimum follow‐up of 2 years were included. Clinical, neuroimaging, EEG, neuropsychological, surgical, histopathological, and molecular‐genetic data were analyzed. Outcomes and potential predictors were assessed across four domains: seizures, antiseizure medication (ASM) use, cognition (Full Scale Intelligence Quotient, FS‐IQ), and postoperative surgical complications. Results: Seventy‐one children fulfilled the inclusion criteria. Fifty‐one (71.8%) had drug‐resistant epilepsy. LEAT plus FCD IIIb were more frequent (43/71, 60.6%) than isolated LEAT (28/71, 39.4%). Gangliogliomas were the most common tumor type (39/71, 54.9%), followed by dysembryoplastic neuroepithelial tumors (16/71, 22.5%). Genetic testing demonstrated internal tandem duplication of the FGFR1 gene in most isolated LEAT cases (OR 11.9, 95% CI 1.32–100, p = .02), while LEAT+FCD IIIb cases were more frequently negative (OR 3.8, 95% CI 1.3–10.9, p = .02). After a median 5.7‐year follow‐up, 64 patients (90.1%) were seizure‐free, and 55 (77.5%) discontinued ASM. Earlier seizure onset, longer epilepsy duration, and a higher number of ASM correlated with lower pre‐ and postoperative FS‐IQ. A postoperative FS‐IQ gain of >15 points occurred in four patients (7.7%). Two patients (2.8%) had unexpected permanent deficits, and 10 (14.1%) had minor temporary deficits. Significance: Epilepsy surgery leads to high rates of freedom from seizures and ASM in pediatric patients with LEAT and LEAT + FCD IIIb. Early surgical intervention can be associated with higher pre‐ and postoperative FS‐IQ. Molecular‐genetic findings suggest distinct neoplastic and dysplastic entities of LEAT and LEAT plus FCD IIIb.
- 27 May 2026
- Published by Wiley in Epileptic Disorders
- Vol. 28 (5) , 1470-1481
Electroclinical characteristics, genetic findings, and complex epilepsy surgery outcomes in children with low‐grade epilepsy‐associated tumors: A comprehensive view
Objective: To evaluate outcomes in relation to epilepsy characteristics and genetic findings in pediatric patients with isolated low‐grade epilepsy‐associated tumors (LEAT) and LEAT plus focal cortical dysplasia type IIIb (FCD IIIb) who underwent epilepsy surgery. Methods: Patients younger than 19 years at the time of surgery, with isolated LEAT or LEAT plus FCD IIIb, and a minimum follow‐up of 2 years were included. Clinical, neuroimaging, EEG, neuropsychological, surgical, histopathological, and molecular‐genetic data were analyzed. Outcomes and potential predictors were assessed across four domains: seizures, antiseizure medication (ASM) use, cognition (Full Scale Intelligence Quotient, FS‐IQ), and postoperative surgical complications. Results: Seventy‐one children fulfilled the inclusion criteria. Fifty‐one (71.8%) had drug‐resistant epilepsy. LEAT plus FCD IIIb were more frequent (43/71, 60.6%) than isolated LEAT (28/71, 39.4%). Gangliogliomas were the most common tumor type (39/71, 54.9%), followed by dysembryoplastic neuroepithelial tumors (16/71, 22.5%). Genetic testing demonstrated internal tandem duplication of the FGFR1 gene in most isolated LEAT cases (OR 11.9, 95% CI 1.32–100, p = .02), while LEAT+FCD IIIb cases were more frequently negative (OR 3.8, 95% CI 1.3–10.9, p = .02). After a median 5.7‐year follow‐up, 64 patients (90.1%) were seizure‐free, and 55 (77.5%) discontinued ASM. Earlier seizure onset, longer epilepsy duration, and a higher number of ASM correlated with lower pre‐ and postoperative FS‐IQ. A postoperative FS‐IQ gain of >15 points occurred in four patients (7.7%). Two patients (2.8%) had unexpected permanent deficits, and 10 (14.1%) had minor temporary deficits. Significance: Epilepsy surgery leads to high rates of freedom from seizures and ASM in pediatric patients with LEAT and LEAT + FCD IIIb. Early surgical intervention can be associated with higher pre‐ and postoperative FS‐IQ. Molecular‐genetic findings suggest distinct neoplastic and dysplastic entities of LEAT and LEAT plus FCD IIIb.
- Open Access
ELECTROCLINICAL CHARACTERISTICS, GENETIC FINDINGS AND COMPLEX EPILEPSY SURGERY OUTCOMES IN CHILDREN WITH LOW-GRADE EPILEPSY-ASSOCIATED TUMORS – A COMPREHENSIVE VIEW
Objective To analyze postsurgical outcomes in relation to epilepsy characteristics and genetic etiology in pediatric patients with isolated low-grade epilepsy associated tumors (LEAT) and LEAT plus focal cortical dysplasia type IIIb (FCD IIIb) who underwent epilepsy surgery. Methods Patients younger than 19 years at the time of epilepsy surgery, with isolated LEAT or LEAT plus FCD IIIb and a minimum follow-up of 2 years were included. Clinical data, neuroimaging, EEG, neuropsychological findings, surgical variables, histopathological and molecular-genetic findings were evaluated. Surgical outcomes were assessed in four domains: seizures, antiseizure medication (ASM) use, cognitive performance changes and complications, including predictor analysis. Results Seventy-three children fulfilled the inclusion criteria, with 53 (72.6%) having drug-resistant epilepsy. LEAT plus FCD IIIb were more frequent than isolated LEAT (44/73, 60.3% vs. 29/73, 39.7%) and gangliogliomas were the most common tumor type (43/73, 58.9%), followed by dysembryoplastic neuroepithelial tumor (19/73, 26.0 %). Genetic testing was more frequently positive in isolated LEAT (20/28) than LEAT plus FCD IIIb (18/43, p = 0.02). At the end of follow-up (median 5.7 years), 66 patients (90.4%) were seizure-free, and 57 (78.1%) had discontinued ASM. Younger age at seizure onset, longer epilepsy duration, and a higher number of ASM were correlated to lower pre- and postoperative IQ. An IQ gain of > 10 pts. postoperatively was present in 8 patients (15.1%). Two patients (2.7%) had an unexpected permanent deficit, while 10 (13.7%) had minor temporary deficit. No additional predictive outcome factors were identified. Significance Epilepsy surgery yields high chances of freedom from seizures and ASM discontinuation. Early surgical intervention in terms of shorter duration of epilepsy and fewer used ASM can be associated to a higher pre- and postoperative IQ. Molecular-genetic differences between isolated LEAT and LEAT plus FCD IIIb suggest distinct neoplastic and dysplastic entities, respectively. Key points A majority of patients with LEAT achieved freedom from seizures and ASM post-surgically. Children with younger age at seizure onset, longer duration of epilepsy and a higher number of ASM used before surgery had lower pre- and postoperative IQ. Genetic cause was detected more often in patients with isolated LEAT vs. LEAT + FCD IIIb implying their neoplastic respectively dysplastic origin.
Open AccessELECTROCLINICAL CHARACTERISTICS, GENETIC FINDINGS AND COMPLEX EPILEPSY SURGERY OUTCOMES IN CHILDREN WITH LOW-GRADE EPILEPSY-ASSOCIATED TUMORS – A COMPREHENSIVE VIEW
Objective To analyze postsurgical outcomes in relation to epilepsy characteristics and genetic etiology in pediatric patients with isolated low-grade epilepsy associated tumors (LEAT) and LEAT plus focal cortical dysplasia type IIIb (FCD IIIb) who underwent epilepsy surgery. Methods Patients younger than 19 years at the time of epilepsy surgery, with isolated LEAT or LEAT plus FCD IIIb and a minimum follow-up of 2 years were included. Clinical data, neuroimaging, EEG, neuropsychological findings, surgical variables, histopathological and molecular-genetic findings were evaluated. Surgical outcomes were assessed in four domains: seizures, antiseizure medication (ASM) use, cognitive performance changes and complications, including predictor analysis. Results Seventy-three children fulfilled the inclusion criteria, with 53 (72.6%) having drug-resistant epilepsy. LEAT plus FCD IIIb were more frequent than isolated LEAT (44/73, 60.3% vs. 29/73, 39.7%) and gangliogliomas were the most common tumor type (43/73, 58.9%), followed by dysembryoplastic neuroepithelial tumor (19/73, 26.0 %). Genetic testing was more frequently positive in isolated LEAT (20/28) than LEAT plus FCD IIIb (18/43, p = 0.02). At the end of follow-up (median 5.7 years), 66 patients (90.4%) were seizure-free, and 57 (78.1%) had discontinued ASM. Younger age at seizure onset, longer epilepsy duration, and a higher number of ASM were correlated to lower pre- and postoperative IQ. An IQ gain of > 10 pts. postoperatively was present in 8 patients (15.1%). Two patients (2.7%) had an unexpected permanent deficit, while 10 (13.7%) had minor temporary deficit. No additional predictive outcome factors were identified. Significance Epilepsy surgery yields high chances of freedom from seizures and ASM discontinuation. Early surgical intervention in terms of shorter duration of epilepsy and fewer used ASM can be associated to a higher pre- and postoperative IQ. Molecular-genetic differences between isolated LEAT and LEAT plus FCD IIIb suggest distinct neoplastic and dysplastic entities, respectively. Key points A majority of patients with LEAT achieved freedom from seizures and ASM post-surgically. Children with younger age at seizure onset, longer duration of epilepsy and a higher number of ASM used before surgery had lower pre- and postoperative IQ. Genetic cause was detected more often in patients with isolated LEAT vs. LEAT + FCD IIIb implying their neoplastic respectively dysplastic origin.
- Open Access
A new perspective on drug‐resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome
Objective: We comprehensively characterized a large pediatric cohort with focal cortical dysplasia (FCD) type 1 to expand the phenotypic spectrum and to identify predictors of postsurgical outcomes. Methods: We included pediatric patients with histopathological diagnosis of isolated FCD type 1 and at least 1 year of postsurgical follow‐up. We systematically reanalyzed clinical, electrophysiological, and radiological features. The results of this reanalysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children ( N = 31) had drug‐resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient [IQ]/developmental quotient scores = 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalographic (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD‐specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI‐negative. In six of eight MRI‐negative cases, fluorodeoxyglucose–positron emission tomography (PET) and subtraction ictal single photon emission computed tomography coregistered to MRI helped localize the dysplastic cortex. Sixteen patients (51.6%) underwent invasive EEG. By the last follow‐up (median = 5 years, interquartile range = 3.3–9 years), seizure freedom was achieved in 71% of patients (22/31), including seven of eight MRI‐negative patients. Antiseizure medications were reduced in 21 patients, with complete withdrawal in six. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long‐term invasive EEG, and specific MRI and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. The applied multilayered presurgical approach helped localize the epileptogenic zone in many previously nonlesional cases, resulting in improved postsurgical seizure outcomes, which are more favorable than previously reported for FCD type 1 patients.
Open AccessA new perspective on drug‐resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome
Objective: We comprehensively characterized a large pediatric cohort with focal cortical dysplasia (FCD) type 1 to expand the phenotypic spectrum and to identify predictors of postsurgical outcomes. Methods: We included pediatric patients with histopathological diagnosis of isolated FCD type 1 and at least 1 year of postsurgical follow‐up. We systematically reanalyzed clinical, electrophysiological, and radiological features. The results of this reanalysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children ( N = 31) had drug‐resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient [IQ]/developmental quotient scores = 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalographic (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD‐specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI‐negative. In six of eight MRI‐negative cases, fluorodeoxyglucose–positron emission tomography (PET) and subtraction ictal single photon emission computed tomography coregistered to MRI helped localize the dysplastic cortex. Sixteen patients (51.6%) underwent invasive EEG. By the last follow‐up (median = 5 years, interquartile range = 3.3–9 years), seizure freedom was achieved in 71% of patients (22/31), including seven of eight MRI‐negative patients. Antiseizure medications were reduced in 21 patients, with complete withdrawal in six. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long‐term invasive EEG, and specific MRI and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. The applied multilayered presurgical approach helped localize the epileptogenic zone in many previously nonlesional cases, resulting in improved postsurgical seizure outcomes, which are more favorable than previously reported for FCD type 1 patients.
- Open Access
Epilepsy surgery in children with operculoinsular epilepsy: Results of a large unicentric cohort
Objective: Epilepsy surgery in the operculoinsular cortex is challenging due to the difficult delineation of the epileptogenic zone and the high risk of postoperative deficits.Methods: Pre‐ and postsurgical data from 30 pediatric patients who underwent operculoinsular cortex surgery at the Motol Epilepsy Center Prague from 2010 to 2022 were analyzed.Results: Focal cortical dysplasia (FCD; n = 15, 50%) was the predominant cause of epilepsy, followed by epilepsy‐associated tumors (n = 5, 17%) and tuberous sclerosis complex (n = 2, 7%). In eight patients where FCD was the most likely etiology, the histology was negative. Seven patients (23%) displayed normal magnetic resonance imaging results. Seizures exhibited diverse semiology and propagation patterns (frontal, perisylvian, and temporal). The ictal and interictal electroencephalographic (EEG) findings were mostly extensive. Multimodal imaging and advanced postprocessing were frequently used. Stereo‐EEG was used for localizing the epileptogenic zone and eloquent cortex in 23 patients (77%). Oblique electrodes were used as guides for better neurosurgeon orientation. The epileptogenic zone was in the dominant hemisphere in 16 patients. At the 2‐year follow‐up, 22 patients (73%) were completely seizure‐free, and eight (27%) experienced a seizure frequency reduction of >50% (International League Against Epilepsy class 3 and 4). Fourteen patients (47%) underwent antiseizure medication tapering; treatment was completely withdrawn in two (7%). Nineteen patients (63%) remained seizure‐free following the definitive outcome assessment (median = 6 years 5 months, range = 2 years to 13 years 5 months postsurgery). Six patients (20%) experienced corona radiata or basal ganglia ischemia; four (13%) improved to mild and one (3%) to moderate hemiparesis. Two patients (7%) operated on in the anterior insula along with frontotemporal resection experienced major complications: pontine ischemia and postoperative brain edema.Significance: Epilepsy surgery in the operculoinsular cortex can lead to excellent patient outcomes. A comprehensive diagnostic approach is crucial for surgical success. Rehabilitation brings a great chance for significant recovery of postoperative deficits.
Open AccessEpilepsy surgery in children with operculoinsular epilepsy: Results of a large unicentric cohort
Objective: Epilepsy surgery in the operculoinsular cortex is challenging due to the difficult delineation of the epileptogenic zone and the high risk of postoperative deficits.Methods: Pre‐ and postsurgical data from 30 pediatric patients who underwent operculoinsular cortex surgery at the Motol Epilepsy Center Prague from 2010 to 2022 were analyzed.Results: Focal cortical dysplasia (FCD; n = 15, 50%) was the predominant cause of epilepsy, followed by epilepsy‐associated tumors (n = 5, 17%) and tuberous sclerosis complex (n = 2, 7%). In eight patients where FCD was the most likely etiology, the histology was negative. Seven patients (23%) displayed normal magnetic resonance imaging results. Seizures exhibited diverse semiology and propagation patterns (frontal, perisylvian, and temporal). The ictal and interictal electroencephalographic (EEG) findings were mostly extensive. Multimodal imaging and advanced postprocessing were frequently used. Stereo‐EEG was used for localizing the epileptogenic zone and eloquent cortex in 23 patients (77%). Oblique electrodes were used as guides for better neurosurgeon orientation. The epileptogenic zone was in the dominant hemisphere in 16 patients. At the 2‐year follow‐up, 22 patients (73%) were completely seizure‐free, and eight (27%) experienced a seizure frequency reduction of >50% (International League Against Epilepsy class 3 and 4). Fourteen patients (47%) underwent antiseizure medication tapering; treatment was completely withdrawn in two (7%). Nineteen patients (63%) remained seizure‐free following the definitive outcome assessment (median = 6 years 5 months, range = 2 years to 13 years 5 months postsurgery). Six patients (20%) experienced corona radiata or basal ganglia ischemia; four (13%) improved to mild and one (3%) to moderate hemiparesis. Two patients (7%) operated on in the anterior insula along with frontotemporal resection experienced major complications: pontine ischemia and postoperative brain edema.Significance: Epilepsy surgery in the operculoinsular cortex can lead to excellent patient outcomes. A comprehensive diagnostic approach is crucial for surgical success. Rehabilitation brings a great chance for significant recovery of postoperative deficits.
- Open Access
Multi-layered Diagnostic Protocol Improves Postsurgical Outcomes in Children with Drug-resistant Epilepsy And Focal Cortical Dysplasia Type 1
Objectives: We comprehensively characterised a large paediatric cohort with histologically confirmed focal cortical dysplasia (FCD) type 1 to demonstrate the role of advanced multimodal pre-surgical evaluation and identify predictors of postsurgical outcomes. Methods: This study comprised a systematic re-analysis of clinical, electrophysiological, and radiological features. The results of this re-analysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children (N = 31) had drug-resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient (IQ)/developmental quotient scores: 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalogram (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD-specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI-negative. In six out of eight MRI-negative cases, fluorodeoxyglucose positron emission tomography (FDG-PET) and subtraction ictal single-photon emission computed tomography co-registered to MRI (SISCOM) helped localise the dysplastic cortex. Sixteen patients (51.6%) underwent stereoelectroencephalography (SEEG). Twenty-eight underwent resective surgery, and three underwent hemispheral disconnection. Seizure freedom was achieved in 71.0% of patients (22/31) by the last follow-up, including seven of the eight MRI-negative patients. Anti-seizure medications (ASMs) were reduced in 21 patients, with complete withdrawal in 5 individuals. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long-term invasive EEG, and specific MRI, and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. Combining advanced MRI protocols with additional neuroimaging techniques helped localise the epileptogenic zone in many previously non-lesional cases. Complex multimodal presurgical approaches (including SEEG) could enhance postsurgical outcomes in these complex patients. Key points: The phenotypic spectrum of paediatric patients with FCD type 1 spans beyond the narrow description of previous studies MRI-negative patients benefit from enhanced precision in localising the epileptogenic zone, facilitated by FDG-PET, SISCOM, and SEEG A complex multimodal presurgical approach could enhance postoperative seizure outcomes in patients with FCD type 1 Paediatric patients with suspected FCD type 1 should be referred to epilepsy surgery centres as soon as possible
Open AccessMulti-layered Diagnostic Protocol Improves Postsurgical Outcomes in Children with Drug-resistant Epilepsy And Focal Cortical Dysplasia Type 1
Objectives: We comprehensively characterised a large paediatric cohort with histologically confirmed focal cortical dysplasia (FCD) type 1 to demonstrate the role of advanced multimodal pre-surgical evaluation and identify predictors of postsurgical outcomes. Methods: This study comprised a systematic re-analysis of clinical, electrophysiological, and radiological features. The results of this re-analysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children (N = 31) had drug-resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient (IQ)/developmental quotient scores: 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalogram (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD-specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI-negative. In six out of eight MRI-negative cases, fluorodeoxyglucose positron emission tomography (FDG-PET) and subtraction ictal single-photon emission computed tomography co-registered to MRI (SISCOM) helped localise the dysplastic cortex. Sixteen patients (51.6%) underwent stereoelectroencephalography (SEEG). Twenty-eight underwent resective surgery, and three underwent hemispheral disconnection. Seizure freedom was achieved in 71.0% of patients (22/31) by the last follow-up, including seven of the eight MRI-negative patients. Anti-seizure medications (ASMs) were reduced in 21 patients, with complete withdrawal in 5 individuals. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long-term invasive EEG, and specific MRI, and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. Combining advanced MRI protocols with additional neuroimaging techniques helped localise the epileptogenic zone in many previously non-lesional cases. Complex multimodal presurgical approaches (including SEEG) could enhance postsurgical outcomes in these complex patients. Key points: The phenotypic spectrum of paediatric patients with FCD type 1 spans beyond the narrow description of previous studies MRI-negative patients benefit from enhanced precision in localising the epileptogenic zone, facilitated by FDG-PET, SISCOM, and SEEG A complex multimodal presurgical approach could enhance postoperative seizure outcomes in patients with FCD type 1 Paediatric patients with suspected FCD type 1 should be referred to epilepsy surgery centres as soon as possible
- Open Access
Epilepsy surgery in children with operculo-insular epilepsy: Results of a large unicentric cohort
Objective Epilepsy surgery in the operculo-insular cortex is challenging due to the difficult delineation of the epileptogenic zone and the high risk of post-operative deficits following resections in this region. Methods Pre- and post-surgical data from 30 pediatric patients who underwent opercular-insular cortex surgery at Motol Epilepsy Center Prague from 2010 to 2022 were analyzed. Results Focal cortical dysplasia (FCD, n = 15) was the predominant cause of epilepsy in the patients studied, followed by epilepsy-associated tumors (n = 5) and tuberous sclerosis complex (n = 2). In eight patients where FCD was the most likely etiology, histology was negative. The epileptogenic zone was in the dominant hemisphere in 16 patients. Variability in seizure semiology and electrophysiological findings necessitated multimodal imaging and advanced post-processing for precise epileptogenic zone localization. Stereoelectroencephalography (SEEG) monitoring was used in 23 patients. The use of oblique electrodes as guides during resection proved beneficial for the neurosurgeon. At the two-year follow-up, 23 patients were seizure-free (ILAE Classification of Outcome 1), and seven experienced a seizure frequency reduction of > 50% (ILAE 4). Nineteen remained seizure-free following the definitive outcome assessment (2–13 years post-surgery). Five from 15 patients operated in posterior insula experienced pyramidal tract ischemia, leading to permanent mild hemiparesis in three patients and moderate hemiparesis in one patient. One patient experienced unexpected pontine ischemia 9 days post-surgery, leading to permanent spastic hemiparesis. Five other patients experienced transient deficits. Significance Despite diagnostic and surgical challenges, epilepsy surgery in the opercular-insular cortex can lead to excellent patient outcomes. A comprehensive diagnostic approach is crucial for surgical success. For surgeries in the posterior insula, ischemia in the pyramidal tract and subsequent hemiparesis of varying severity should be anticipated. However, in pediatric patients, there is a great chance for significant recovery with proper rehabilitation. Key points Despite the diagnostic and surgical challenges, patients who underwent operculo-insular cortex surgery achieved excellent outcomes. Seizures from the operculo-insular region exhibit diverse semiology and propagation patterns (i.e., frontal, perisylvian, and temporal). An initially negative MRI finding is common. Video EEG typically reveals an extensive finding. A multimodal diagnostic approach is crucial. SEEG was necessary in a significant number of cases, and the use of oblique electrodes as guides proved beneficial for the neurosurgeon. For surgeries in the posterior insula, ischemia in the pyramidal tract and subsequent hemiparesis of varying severity should be anticipated.
Open AccessEpilepsy surgery in children with operculo-insular epilepsy: Results of a large unicentric cohort
Objective Epilepsy surgery in the operculo-insular cortex is challenging due to the difficult delineation of the epileptogenic zone and the high risk of post-operative deficits following resections in this region. Methods Pre- and post-surgical data from 30 pediatric patients who underwent opercular-insular cortex surgery at Motol Epilepsy Center Prague from 2010 to 2022 were analyzed. Results Focal cortical dysplasia (FCD, n = 15) was the predominant cause of epilepsy in the patients studied, followed by epilepsy-associated tumors (n = 5) and tuberous sclerosis complex (n = 2). In eight patients where FCD was the most likely etiology, histology was negative. The epileptogenic zone was in the dominant hemisphere in 16 patients. Variability in seizure semiology and electrophysiological findings necessitated multimodal imaging and advanced post-processing for precise epileptogenic zone localization. Stereoelectroencephalography (SEEG) monitoring was used in 23 patients. The use of oblique electrodes as guides during resection proved beneficial for the neurosurgeon. At the two-year follow-up, 23 patients were seizure-free (ILAE Classification of Outcome 1), and seven experienced a seizure frequency reduction of > 50% (ILAE 4). Nineteen remained seizure-free following the definitive outcome assessment (2–13 years post-surgery). Five from 15 patients operated in posterior insula experienced pyramidal tract ischemia, leading to permanent mild hemiparesis in three patients and moderate hemiparesis in one patient. One patient experienced unexpected pontine ischemia 9 days post-surgery, leading to permanent spastic hemiparesis. Five other patients experienced transient deficits. Significance Despite diagnostic and surgical challenges, epilepsy surgery in the opercular-insular cortex can lead to excellent patient outcomes. A comprehensive diagnostic approach is crucial for surgical success. For surgeries in the posterior insula, ischemia in the pyramidal tract and subsequent hemiparesis of varying severity should be anticipated. However, in pediatric patients, there is a great chance for significant recovery with proper rehabilitation. Key points Despite the diagnostic and surgical challenges, patients who underwent operculo-insular cortex surgery achieved excellent outcomes. Seizures from the operculo-insular region exhibit diverse semiology and propagation patterns (i.e., frontal, perisylvian, and temporal). An initially negative MRI finding is common. Video EEG typically reveals an extensive finding. A multimodal diagnostic approach is crucial. SEEG was necessary in a significant number of cases, and the use of oblique electrodes as guides proved beneficial for the neurosurgeon. For surgeries in the posterior insula, ischemia in the pyramidal tract and subsequent hemiparesis of varying severity should be anticipated.